Monsanto Forecasted to Post Q2 2018 Earnings of $3.50 Per Share (NYSE:MON)

Monsanto (NYSE:MON) – Stock analysts at Jefferies Group increased their Q2 2018 earnings per share estimates for shares of Monsanto in a report released on Friday, according to Zacks Investment Research. Jefferies Group analyst L. Alexander now anticipates that the basic materials company will earn $3.50 per share for the quarter, up from their previous forecast of $3.29. Jefferies Group also issued estimates for Monsanto’s FY2019 earnings at $7.00 EPS and FY2020 earnings at $7.30 EPS.

Monsanto (NYSE:MON) last released its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. During the same period in the prior year, the business earned $0.21 earnings per share. The company’s revenue for the quarter was up .3% on a year-over-year basis.

A number of other equities research analysts have also recently weighed in on the company. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Royal Bank of Canada reaffirmed a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Wednesday, November 15th. Macquarie cut Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Wells Fargo & Co raised their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $126.40.

Monsanto (NYSE MON) traded down $0.35 during mid-day trading on Monday, reaching $119.36. The company had a trading volume of 1,900,000 shares, compared to its average volume of 3,050,000. Monsanto has a 12-month low of $106.97 and a 12-month high of $122.79. The firm has a market cap of $52,540.00, a PE ratio of 22.06, a price-to-earnings-growth ratio of 1.71 and a beta of 1.04. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 annualized dividend and a dividend yield of 1.81%. Monsanto’s dividend payout ratio (DPR) is currently 39.93%.

In other news, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at approximately $5,903,336. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Steven Mizell sold 8,100 shares of Monsanto stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the sale, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.

Several institutional investors have recently made changes to their positions in MON. Federated Investors Inc. PA grew its stake in shares of Monsanto by 0.5% during the second quarter. Federated Investors Inc. PA now owns 9,555 shares of the basic materials company’s stock worth $1,131,000 after purchasing an additional 46 shares during the period. DSAM Partners London Ltd acquired a new stake in shares of Monsanto during the second quarter worth $2,009,000. Principal Financial Group Inc. grew its stake in shares of Monsanto by 3.1% during the second quarter. Principal Financial Group Inc. now owns 650,748 shares of the basic materials company’s stock worth $77,023,000 after purchasing an additional 19,676 shares during the period. OZ Management LP acquired a new stake in shares of Monsanto during the second quarter worth $242,786,000. Finally, Wesbanco Bank Inc. lifted its holdings in Monsanto by 24.7% during the second quarter. Wesbanco Bank Inc. now owns 16,842 shares of the basic materials company’s stock worth $1,993,000 after acquiring an additional 3,340 shares in the last quarter. 75.37% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/01/16/monsanto-mon-to-post-q2-2018-earnings-of-3-50-per-share-jefferies-group-forecasts.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Get a free copy of the Zacks research report on Monsanto (MON)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply